HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dana T Aftab Selected Research

Angiogenesis Inhibitors

10/2023Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma.
7/2011VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dana T Aftab Research Topics

Disease

14Neoplasms (Cancer)
10/2023 - 06/2007
5Glioblastoma (Glioblastoma Multiforme)
10/2023 - 04/2011
4Prostatic Neoplasms (Prostate Cancer)
01/2018 - 01/2013
4Neoplasm Metastasis (Metastasis)
02/2014 - 07/2011
3Renal Cell Carcinoma (Grawitz Tumor)
09/2021 - 07/2016
3Hypoxia (Hypoxemia)
01/2016 - 07/2011
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 06/2007
1Circulating Neoplastic Cells
01/2018
1medullary Thyroid cancer
12/2016
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2016
1Hypertension (High Blood Pressure)
07/2016
1Aspergillosis
07/2016
1Aspiration Pneumonia
07/2016
1Disease Progression
07/2016
1Fatigue
07/2016
1Carcinogenesis
11/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2012
1Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2012

Drug/Important Bio-Agent (IBA)

14cabozantinibIBA
09/2021 - 07/2011
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2023 - 07/2011
4Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2016
3EverolimusFDA Link
09/2021 - 07/2016
3Tyrosine Kinase InhibitorsIBA
01/2019 - 07/2016
2Angiogenesis InhibitorsIBA
10/2023 - 07/2011
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2019 - 01/2018
2ErbB Receptors (EGF Receptor)IBA
01/2019 - 06/2007
2Phosphotransferases (Kinase)IBA
02/2014 - 07/2011
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2014 - 07/2011
1Proto-Oncogene Proteins c-metIBA
01/2018
1Prostate-Specific Antigen (Semenogelase)IBA
01/2018
1Lomustine (CCNU)FDA Link
10/2017
1Imatinib Mesylate (Gleevec)FDA Link
12/2016
1ClusterinIBA
01/2016
1Alkaline PhosphataseIBA
01/2016
1Interleukin-8 (Interleukin 8)IBA
01/2016
1Cancer VaccinesIBA
11/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2014
1Hormones (Hormone)IBA
01/2013
1AndrogensIBA
01/2013
1Sunitinib (Sutent)FDA Link
03/2012
1CrizotinibIBA
03/2012
12- (4- (3- quinolin- 6- ylmethyl- 3H- (1,2,3)triazolo(4,5- b)pyrazin- 5- yl)pyrazol- 1- yl)ethanolIBA
03/2012
1GSK 1363089IBA
07/2011
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
07/2011
1Temozolomide (Temodar)FDA LinkGeneric
04/2011
1LuciferasesIBA
04/2011
1XL765IBA
04/2011
1XL647IBA
06/2007

Therapy/Procedure

7Therapeutics
10/2023 - 06/2007
4Castration
01/2018 - 01/2013
1Immunotherapy
11/2014